Pressure BioSciences (OTCQB: PBIO) this morning announced
the award of a key new U.S. patent, entitled ”Flow-through High Hydrostatic
Pressure Microfluidic Sample Preparation Device and Related Methods Therefor.”
The company’s creation provides a path for integration of automated
”Hands-Free” sample prep workflows utilizing PBIO’s patented high-pressure
platform technologies. The newly issued patent brings Pressure BioSciences’
Intellectual Property (”IP”) to a total of 21 issued patents. “This long-anticipated
patent is a very important development for the Company on multiple fronts, and
the timing of its issuance could not be better. This invention covers key
elements of our plans for developing automated, ”hands-free” sample handling
for the next generation of our high-pressure sample preparation platform
technologies. This invention also enables a unique capability for maintaining
high pressure in a flow-through format (rather than current batch processing),
which we expect will facilitate the development of new, automated continuous
process monitoring tools applicable to diverse segments of the life sciences
industry. Finally, we believe this novel flow-through concept offers critical
enablement for future system design strategies for epitope characterization, an
emerging area in development and production of biotherapeutics that could
revolutionize personalized therapy for numerous medical conditions, including
autoimmune diseases and a variety of rare medical disorders,” Pressure
BioSciences Vice President of Research and Development Dr. Alexander Lazarev
stated in the news release.
To view the full press release, visit http://ibn.fm/BGz9p
About Pressure BioSciences Inc.
Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the
development and sale of innovative, broadly enabling, pressure-based solutions
for the worldwide life sciences industry. Our products are based on the unique
properties of both constant (i.e., static) and alternating (i.e., pressure
cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling
technology platform that uses alternating cycles of hydrostatic pressure
between ambient and ultra-high levels to safely and reproducibly control
bio-molecular interactions (e.g., cell lysis, biomolecule extraction). Our
primary focus is in the development of PCT-based products for biomarker and
target discovery, drug design and development, biotherapeutics characterization
and quality control, soil & plant biology, forensics, and counter-bioterror
applications. Additionally, major new market opportunities have emerged in the
use of our pressure-based technologies in the following areas: (1) the use of
our recently acquired PreEMT technology from BaroFold, Inc. to allow entry into
the biologics contract research services sector, and (2) the use of our
recently-patented, scalable, high-efficiency, pressure-based Ultra Shear
Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise
immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality,
homogenized, extended shelf-life or room temperature stable low-acid liquid
foods that cannot be effectively preserved using existing non-thermal
technologies. For more information, visit the company’s website at www.PressureBiosciences.com
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide
a rapid summary of corporate news that catch the attention of QualityStocks.
QualityStocksBreaks are designed to keep investors up to date on important and
breaking news in the small-cap and micro-cap markets. Spanning all industries,
including energy, entertainment, telecommunications, healthcare, retail and
more, these news breaks deliver opportunities the investment community may have
missed. Whether it is earnings results, mergers and acquisitions, or any other
market-moving news, our news breaks keep you in the know. QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment